ArticleJournal of family medicine and primary care2025
An observational study of clinical profile and EEG changes in patients with metabolic encephalopathy.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess the clinical profile and electroencephalography (EEG) abnormal patterns in patients with metabolic encephalopathy (ME). Methods: A cross-sectional observational study was conducted on 80 diagnosed patients of ME over a period of 24 months from January 2019 until January 2021. Causes of ME were determined. Glasgow coma score (GCS) was recorded. Routine biochemical investigations were done, and EEG patterns were recorded. The outcome measures were association of EEG patterns with the cause of ME. Results: The mean age was 39.62 ± 14.98 years, with 61.3% being men. The mean GCS was 13.28 ± 0.96. The cause of ME was single in 34 (42.5%) cases and multifactorial in 46 (57.5%) cases. Hyperammonemia was present in all patients. Abnormal EEG findings were observed in 7 (8.75%) patients in the form of slow posterior background rhythm. The patients with normal EEG had comparable mean GCS as those with abnormal EEG (13.30 ± 0.97 vs. 13.14 ± 0.90, Conclusion: ME is seen in a wide age group of patients with majority being in the age group of 21 to 40 years followed by 41 to 60 years. It carries a male predominance with multifactorial causes where hyperammonemia remains the most common metabolic abnormality. Cases may either have a single cause or multiple causes for metabolic abnormality. EEG abnormality was seen in only 8.7% cases with no statistical relation with causes of metabolic abnormality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.